2023-02-012024-01-312024-01-31false11786446Smile Perfections Limited2024-10-3186230iso4217:GBPxbrli:pure117864462023-02-01117864462024-01-31117864462023-02-012024-01-31117864462022-02-01117864462023-01-31117864462022-02-012023-01-3111786446bus:SmallEntities2023-02-012024-01-3111786446bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3111786446bus:AbridgedAccounts2023-02-012024-01-3111786446bus:PrivateLimitedCompanyLtd2023-02-012024-01-3111786446core:WithinOneYear2024-01-3111786446core:AfterOneYear2024-01-3111786446core:WithinOneYear2023-01-3111786446core:AfterOneYear2023-01-3111786446core:ShareCapital2024-01-3111786446core:SharePremium2024-01-3111786446core:RevaluationReserve2024-01-3111786446core:OtherReservesSubtotal2024-01-3111786446core:RetainedEarningsAccumulatedLosses2024-01-3111786446core:ShareCapital2023-01-3111786446core:SharePremium2023-01-3111786446core:RevaluationReserve2023-01-3111786446core:OtherReservesSubtotal2023-01-3111786446core:RetainedEarningsAccumulatedLosses2023-01-3111786446core:LandBuildings2024-01-3111786446core:PlantMachinery2024-01-3111786446core:Vehicles2024-01-3111786446core:FurnitureFittings2024-01-3111786446core:OfficeEquipment2024-01-3111786446core:NetGoodwill2024-01-3111786446core:IntangibleAssetsOtherThanGoodwill2024-01-3111786446core:ListedExchangeTraded2024-01-3111786446core:UnlistedNon-exchangeTraded2024-01-3111786446core:LandBuildings2023-01-3111786446core:PlantMachinery2023-01-3111786446core:Vehicles2023-01-3111786446core:FurnitureFittings2023-01-3111786446core:OfficeEquipment2023-01-3111786446core:NetGoodwill2023-01-3111786446core:IntangibleAssetsOtherThanGoodwill2023-01-3111786446core:ListedExchangeTraded2023-01-3111786446core:UnlistedNon-exchangeTraded2023-01-3111786446core:LandBuildings2023-02-012024-01-3111786446core:PlantMachinery2023-02-012024-01-3111786446core:Vehicles2023-02-012024-01-3111786446core:FurnitureFittings2023-02-012024-01-3111786446core:OfficeEquipment2023-02-012024-01-3111786446core:NetGoodwill2023-02-012024-01-3111786446core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3111786446core:ListedExchangeTraded2023-02-012024-01-3111786446core:UnlistedNon-exchangeTraded2023-02-012024-01-3111786446core:MoreThanFiveYears2023-02-012024-01-3111786446core:Non-currentFinancialInstruments2024-01-3111786446core:Non-currentFinancialInstruments2023-01-3111786446dpl:CostSales2023-02-012024-01-3111786446dpl:DistributionCosts2023-02-012024-01-3111786446core:LandBuildings2023-02-012024-01-3111786446core:PlantMachinery2023-02-012024-01-3111786446core:Vehicles2023-02-012024-01-3111786446core:FurnitureFittings2023-02-012024-01-3111786446core:OfficeEquipment2023-02-012024-01-3111786446dpl:AdministrativeExpenses2023-02-012024-01-3111786446core:NetGoodwill2023-02-012024-01-3111786446core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3111786446dpl:GroupUndertakings2023-02-012024-01-3111786446dpl:ParticipatingInterests2023-02-012024-01-3111786446dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3111786446core:ListedExchangeTraded2023-02-012024-01-3111786446dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3111786446core:UnlistedNon-exchangeTraded2023-02-012024-01-3111786446dpl:CostSales2022-02-012023-01-3111786446dpl:DistributionCosts2022-02-012023-01-3111786446core:LandBuildings2022-02-012023-01-3111786446core:PlantMachinery2022-02-012023-01-3111786446core:Vehicles2022-02-012023-01-3111786446core:FurnitureFittings2022-02-012023-01-3111786446core:OfficeEquipment2022-02-012023-01-3111786446dpl:AdministrativeExpenses2022-02-012023-01-3111786446core:NetGoodwill2022-02-012023-01-3111786446core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3111786446dpl:GroupUndertakings2022-02-012023-01-3111786446dpl:ParticipatingInterests2022-02-012023-01-3111786446dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3111786446core:ListedExchangeTraded2022-02-012023-01-3111786446dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3111786446core:UnlistedNon-exchangeTraded2022-02-012023-01-3111786446core:NetGoodwill2024-01-3111786446core:IntangibleAssetsOtherThanGoodwill2024-01-3111786446core:LandBuildings2024-01-3111786446core:PlantMachinery2024-01-3111786446core:Vehicles2024-01-3111786446core:FurnitureFittings2024-01-3111786446core:OfficeEquipment2024-01-3111786446core:AfterOneYear2024-01-3111786446core:WithinOneYear2024-01-3111786446core:ListedExchangeTraded2024-01-3111786446core:UnlistedNon-exchangeTraded2024-01-3111786446core:ShareCapital2024-01-3111786446core:SharePremium2024-01-3111786446core:RevaluationReserve2024-01-3111786446core:OtherReservesSubtotal2024-01-3111786446core:RetainedEarningsAccumulatedLosses2024-01-3111786446core:NetGoodwill2023-01-3111786446core:IntangibleAssetsOtherThanGoodwill2023-01-3111786446core:LandBuildings2023-01-3111786446core:PlantMachinery2023-01-3111786446core:Vehicles2023-01-3111786446core:FurnitureFittings2023-01-3111786446core:OfficeEquipment2023-01-3111786446core:AfterOneYear2023-01-3111786446core:WithinOneYear2023-01-3111786446core:ListedExchangeTraded2023-01-3111786446core:UnlistedNon-exchangeTraded2023-01-3111786446core:ShareCapital2023-01-3111786446core:SharePremium2023-01-3111786446core:RevaluationReserve2023-01-3111786446core:OtherReservesSubtotal2023-01-3111786446core:RetainedEarningsAccumulatedLosses2023-01-3111786446core:NetGoodwill2022-02-0111786446core:IntangibleAssetsOtherThanGoodwill2022-02-0111786446core:LandBuildings2022-02-0111786446core:PlantMachinery2022-02-0111786446core:Vehicles2022-02-0111786446core:FurnitureFittings2022-02-0111786446core:OfficeEquipment2022-02-0111786446core:AfterOneYear2022-02-0111786446core:WithinOneYear2022-02-0111786446core:ListedExchangeTraded2022-02-0111786446core:UnlistedNon-exchangeTraded2022-02-0111786446core:ShareCapital2022-02-0111786446core:SharePremium2022-02-0111786446core:RevaluationReserve2022-02-0111786446core:OtherReservesSubtotal2022-02-0111786446core:RetainedEarningsAccumulatedLosses2022-02-0111786446core:AfterOneYear2023-02-012024-01-3111786446core:WithinOneYear2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3111786446core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3111786446core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3111786446core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3111786446core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3111786446core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3111786446bus:Director12023-02-012024-01-3111786446bus:Director22023-02-012024-01-31

Smile Perfections Limited

Registered Number
11786446
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

Smile Perfections Limited
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

PALLIPATT, Juttes, Dr
PALLIPATT, Pratima, Dr

Registered Address

34 Harborough Road
Leicester
LE2 4LA

Registered Number

11786446 (England and Wales)
Smile Perfections Limited
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3285,077288,715
Investments4781,584781,584
1,066,6611,070,299
Current assets
Stocks30,0002,000
Debtors4,98723,853
Cash at bank and on hand534,321627,247
569,308653,100
Creditors amounts falling due within one year(426,085)(635,841)
Net current assets (liabilities)143,22317,259
Total assets less current liabilities1,209,8841,087,558
Creditors amounts falling due after one year(81,727)(405,782)
Net assets1,128,157681,776
Capital and reserves
Called up share capital100100
Profit and loss account1,128,057681,676
Shareholders' funds1,128,157681,776
The financial statements were approved and authorised for issue by the Board of Directors on 31 October 2024, and are signed on its behalf by:
PALLIPATT, Juttes, Dr
Director
Registered Company No. 11786446
Smile Perfections Limited
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings10
Plant and machinery10
Vehicles4
Office Equipment4
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20242023
Average number of employees during the year75
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 February 23350,837
Additions96,695
Disposals(68,092)
At 31 January 24379,441
Depreciation and impairment
At 01 February 2362,121
Charge for year50,618
On disposals(18,376)
At 31 January 2494,363
Net book value
At 31 January 24285,077
At 31 January 23288,715
4.Fixed asset investments
The company owns 100% of the issued shares capital of Olive Tree Dental Practice, a company registered in England & Wales.

Total

£
Cost or valuation
At 01 February 23781,584
At 31 January 24781,584
Net book value
At 31 January 24781,584
At 31 January 23781,584